Carol Moore: Daily

The world's top animal health firm is targeting cancer and heart disease in pets, deploying a multi-billion dollar R&D strategy to lead the next era.

Commercial Metals Company's $675M acquisition of CP&P and pending Foley deal signal a major pivot, creating a precast concrete leader for an infrastructure boom.

Record Q3 results fuel Volatus Aerospace's expansion in defense and commercial drones, with a strategic focus on Canadian manufacturing and supply chains.

Genmab's routine insider transaction report isn't just regulatory noise. It reveals how data-driven innovation is tied to long-term executive strategy.

With $4.25M in new financing, Pulse Oil is betting big on EOR to revive a mature oilfield. Early data shows a 20% production jump.

Xeriant is betting its future on a high-discipline R&D unit. By mimicking giants like Lockheed and Palantir, can it turn ambition into revenue?

A management-led buyout of China's top mobile charging firm faces a hostile counter-bid, sparking a high-stakes shareholder showdown.

A tiny transaction by an executive's associate reveals the immense power of market regulation and the high bar for corporate transparency.

Mercanto Holdings enters Québec's untapped vape market with a calculated product and hardware strategy, aiming for a key share of a lucrative new category.

A new burger joint in Oregon seems unrelated to medicine, but its data-driven expansion and customer tech offer a playbook for AI innovation in healthcare.

Wolters Kluwer's Expert AI promises to save preparers hours, but the real story is how this technology is reshaping the future of the tax profession.

Northern Venture Trust's successful £15.37M equity issue signals strong investor confidence, with new capital poised to back the next generation of UK AI and HealthTech startups.

Beyond greenwashing, new case studies show how AI-driven platforms deliver quantifiable gains in efficiency, compliance, and investor confidence.

Euronext swaps low-cost debt for a pricier, longer-term bond. This isn't a crisis, but a calculated move to fund expansion and secure its future.

Hall Chadwick's $207M IPO signals a renewed appetite for SPACs. For capital-hungry AI health tech firms, this could be a new path to the public market.

PFLT posts strong fiscal year results, launching a new joint venture and acquiring a $250M portfolio to drive future income amid a dynamic market.

A key acquisition in the emergency vehicle sector reveals a deeper trend: how AI and advanced data systems are making emergency vehicles too complex for local shops.

Corporación América Airports reports its highest-ever EBITDA, driven by traffic growth that outpaces rivals and bold new projects in Iraq and Angola.

With a leaner profile, BioLineRx bets on a novel glioblastoma drug while advancing its diverse pipeline. A deep dive into the strategy and the science.

Harley-Davidson is clearing debt to invest in the future. Healthcare leaders should take note: this is how you fund a real AI transformation.